BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/28/2023 12:59:29 PM | Browse: 306 | Download: 713
 |
Received |
|
2022-10-29 10:41 |
|
Peer-Review Started |
|
2022-10-29 10:43 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-01-03 07:31 |
|
Revised |
|
2023-01-13 11:10 |
|
Second Decision |
|
2023-03-10 03:18 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-03-14 18:20 |
|
Articles in Press |
|
2023-03-14 18:20 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-03-20 09:01 |
|
Publish the Manuscript Online |
|
2023-03-28 12:59 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Obesity and novel management of inflammatory bowel disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jee Hyun Kim, Chang-Myung Oh and Jun Hwan Yoo |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Research Foundation of Korea grant from the Korean government, the Ministry of Science and ICT |
NRF-2020R1F1A1066323, NRF-2021R1F1A1061550 |
|
| Corresponding Author |
Jun Hwan Yoo, MD, PhD, Assistant Professor, Department of Gastroenterology, CHA Bundang Medical Center, CHA University School of Medicine, 59 Yatap-ro, Bundang-gu, Seongnam 13496, South Korea. jhyoo@cha.ac.kr |
| Key Words |
Obesity; Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis |
| Core Tip |
Obesity is prevalent within the inflammatory bowel disease (IBD) population, particularly in newly developed countries. The dysfunction of mesenteric fat worsens the inflammatory course of Crohn’s disease and may induce formation of strictures or fistulas. Furthermore, obesity may affect the disease course or treatment response of IBD. Along with the increasing data that support pathophysiologic and epidemiologic relationship between obesity and IBD, attention is being focused on obesity control as a novel management of IBD. The main purpose of this review is to describe the influence of obesity on the outcomes of IBD treatment and to present the current status of pharmacologic or surgical anti-obesity treatments in IBD patients. |
| Publish Date |
2023-03-28 12:59 |
| Citation |
Kim JH, Oh CM, Yoo JH. Obesity and novel management of inflammatory bowel disease. World J Gastroenterol 2023; 29(12): 1779-1794 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i12/1779.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i12.1779 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
